ES557427A0 - Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas - Google Patents

Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas

Info

Publication number
ES557427A0
ES557427A0 ES557427A ES557427A ES557427A0 ES 557427 A0 ES557427 A0 ES 557427A0 ES 557427 A ES557427 A ES 557427A ES 557427 A ES557427 A ES 557427A ES 557427 A0 ES557427 A0 ES 557427A0
Authority
ES
Spain
Prior art keywords
tetrahidroimidazoquinazolinonas
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557427A
Other languages
English (en)
Other versions
ES8800224A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858514207A external-priority patent/GB8514207D0/en
Priority claimed from GB858527208A external-priority patent/GB8527208D0/en
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of ES8800224A1 publication Critical patent/ES8800224A1/es
Publication of ES557427A0 publication Critical patent/ES557427A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES557427A 1985-06-05 1987-02-26 Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas Expired ES8800224A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858514207A GB8514207D0 (en) 1985-06-05 1985-06-05 Cardiac stimulants
GB858527208A GB8527208D0 (en) 1985-11-05 1985-11-05 Cardiac stimulants

Publications (2)

Publication Number Publication Date
ES8800224A1 ES8800224A1 (es) 1987-10-16
ES557427A0 true ES557427A0 (es) 1987-10-16

Family

ID=26289332

Family Applications (2)

Application Number Title Priority Date Filing Date
ES555723A Expired ES8708139A1 (es) 1985-06-05 1986-06-04 Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES557427A Expired ES8800224A1 (es) 1985-06-05 1987-02-26 Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES555723A Expired ES8708139A1 (es) 1985-06-05 1986-06-04 Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.

Country Status (16)

Country Link
US (1) US4783467A (es)
EP (1) EP0205280A3 (es)
KR (1) KR870001362B1 (es)
CN (1) CN86103833A (es)
AU (1) AU562773B2 (es)
CA (1) CA1270486A (es)
DK (1) DK262486A (es)
ES (2) ES8708139A1 (es)
FI (1) FI862375A (es)
GR (1) GR861425B (es)
HU (1) HU196408B (es)
IL (1) IL79003A0 (es)
NO (1) NO862233L (es)
NZ (1) NZ216386A (es)
PT (1) PT82702B (es)
YU (1) YU95186A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8426429B2 (en) * 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) * 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
WO2022199627A1 (en) * 2021-03-23 2022-09-29 National Institute Of Biological Sciences, Beijing Polycyclic compounds and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
EP0054180A3 (de) * 1980-12-16 1982-12-01 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung eines Imidazochinazolinonderivates
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
US4593029A (en) * 1984-02-15 1986-06-03 Syntex (U.S.A.) Inc. Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents

Also Published As

Publication number Publication date
FI862375A (fi) 1986-12-06
NO862233D0 (no) 1986-06-04
ES8800224A1 (es) 1987-10-16
IL79003A0 (en) 1986-09-30
DK262486A (da) 1987-02-16
HUT41793A (en) 1987-05-28
KR870000338A (ko) 1987-02-17
PT82702B (pt) 1988-12-15
EP0205280A3 (en) 1988-11-30
PT82702A (en) 1986-07-01
FI862375A0 (fi) 1986-06-04
NO862233L (no) 1986-12-08
ES8708139A1 (es) 1987-09-16
AU5842786A (en) 1986-12-11
DK262486D0 (da) 1986-06-04
CA1270486A (en) 1990-06-19
YU95186A (en) 1988-04-30
ES555723A0 (es) 1987-09-16
CN86103833A (zh) 1986-12-31
KR870001362B1 (ko) 1987-07-20
US4783467A (en) 1988-11-08
NZ216386A (en) 1988-08-30
HU196408B (en) 1988-11-28
EP0205280A2 (en) 1986-12-17
AU562773B2 (en) 1987-06-18
GR861425B (en) 1986-10-02

Similar Documents

Publication Publication Date Title
ES557743A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES555435A0 (es) Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras
ES555868A0 (es) Un procedimiento para la preparacion de sulfonamidas
ES557413A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES553602A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
ES557427A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES551508A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES552986A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES551129A0 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas
ES552185A0 (es) Un procedimiento para la preparacion de uretano
ES555670A0 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
ES556807A0 (es) Un procedimiento para la preparacion de nuevos 11-metileno-esteroides.
ES551506A0 (es) Un procedimiento para la preparacion de etanodiimidamidas
ES552186A0 (es) Un procedimiento para la preparacion de 7-(dimetilaminometilen)amino-9a-metoximitosano cristalino